Cynthia L Cwi

This inventor holds 12 USPTO granted patents. Top assignees: Eli Lilly and Company, Athena Neurosciences, Inc., Elan Pharmaceuticals, Inc.. Active years: 1998-2005.

USPTO Granted Patents = 12

% Patents Active = 33.3

Average Co-Inventor Count = 13.4

ph-index = 4

Forward Citations = 69(Granted Patents)

Company Filing History:

3 out of 4,509

Eli Lilly and Company

patents

1 out of 35

Athena Neurosciences, Inc.

patents

1 out of 202

Elan Pharmaceuticals, Inc.

patents

4. 9 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2005

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6951854 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-10-04),

2. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),

3. 6683075 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use (2004-01-27),

4. 6667305 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-12-23),

5. 6653303 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-11-25),

6. 6635632 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-21),

7. 6632811 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-14),

8. 6569851 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-27),

9. 6559141 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-06),

10. 6544978 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-08),

11. 6541466 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-01),

12. 5785927 - Vessel handling system useful for combinatorial chemistry (1998-07-28),

Title: Innovations of Cynthia L Cwi

Introduction

Cynthia L Cwi is a prominent inventor based in Indianapolis, IN, known for her significant contributions to the field of pharmaceuticals. With a total of 12 patents to her name, she has made remarkable strides in developing compounds that have the potential to treat Alzheimer's disease.

Latest Patents

Cynthia's latest patents include innovative compounds such as cycloalkyl, lactam, lactone, and related compounds. These compounds are designed to inhibit the release and synthesis of β-amyloid peptide, which is crucial in the treatment of Alzheimer's disease. The patents also encompass pharmaceutical compositions that utilize these compounds, providing methods for both prophylactic and therapeutic treatment of the disease.

Career Highlights

Throughout her career, Cynthia has worked with notable companies, including Eli Lilly and Company. Her work has focused on developing pharmaceutical solutions that address critical health issues, particularly in neurodegenerative diseases.

Collaborations

Cynthia has collaborated with esteemed colleagues such as Thomas Charles Britton and Jon Kevin Reel, contributing to the advancement of her research and innovations.

Conclusion

Cynthia L Cwi's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in the fight against Alzheimer's disease. Her patents and collaborations highlight her dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]